John Santini, its boss, says his company is working on drug delivery with a big pharmaceuticals firm, and that his laboratory curiosity will be a commercial reality within three to five years.
But several biologists said they believed that the laboratory technique used to birth it would soon be applied to other strains of bacteria with commercial potential.